Role of TGF-b In Excessive Scarring: A Cutaneous Model

TGF-b 在过度疤痕形成中的作用：皮肤模型

• 批准号: 6725383
• 负责人: THOMAS Anthony MUSTOE
• 金额: $ 24.73万
• 依托单位: NORTHWESTERN UNIVERSITY AT CHICAGO
• 依托单位国家: 美国
• 财政年份: 2002
• 资助国家: 美国
• 起止时间: 2002-04-01 至 2006-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6725383
• 关键词: biological signal transduction; collagen; ear surgery; gene expression; gene therapy; genetic transcription; growth factor receptors; hypertrophy; laboratory rabbit; neutralizing antibody; polymerase chain reaction; protein biosynthesis; protein isoforms; protein structure function; receptor expression; scars; skin disorder diagnosis; steroids; tissue /cell culture; transfection /expression vector; transforming growth factors; wound healing

Excessive, or hypertrophic, scarring at sites of cutaneous injury often produces functional and aesthetic deficits that can strongly impact the function of an individual in society. Our long-term goal is to develop diagnostic and therapeutic treatments that promote normal resolution of cutaneous wounds without excessive scar formation. Our preliminary work has focused on demonstrating the clinical relevance of a rabbit model of hypertrophic scarring to the human condition. This model mimics the human condition in a variety of ways including responsiveness to steroid and occlusive treatments and a reduced hypertrophy with aging. Most importantly, the hypertrophy of our model and humans is due to excessive production of extracellular matrix, primarily collagen. The most powerful regulator of collagen synthesis during wounding is the TGFbeta family of cytokines. Our central hypothesis is that TGFbeta regulates wound healing and scarring in a manner that the preponderance of its three isoforms and the temporal sequence of their abundance and appearance determine the scarring outcome of a wound healing response. Furthermore, we hypothesize that the TGFbeta receptors (I and 11) and the Smad members of the TGFbeta intracellular signalling components play critical roles in the maintenance of the hypertrophic state. These hypotheses will be tested using our clinically relevant rabbit hypertrophic scarring model. Our Specific Aims are: (1) To support the hypothesis that the ratio and temporal pattern of the appearance of TGFbeta isoforms and their overall impact on collagen synthesis is critical to the importance of the development of hypertrophic scar vs. normal scar utilizing our unique hypertrophic scar model in the rabbit ear. (2) To examine the hypothesis that alterations in the expression of TGFbeta receptors temporally, in absolute numbers, and ratios are important in the development of hypertrophic scar utilizing a gene therapy approach, both overexpressing Type I and Type II receptors, and blocking them with dominant negative receptors. This novel approach of modifying receptor expression in vivo will be examined for its potential therapeutic implications. (3) To further examine the hypothesis that TGFbeta isoform expression is critical to the development of hypertrophic scar by altering TGFbeta signal transduction through viral and non-viral gene therapy approaches of altering expression of SMAD 3,4,7, and measuring the impact on TGFbeta isoform expression, development of hypertrophic scar, and collagen 1 expression.

皮肤损伤部位的过度或肥大的疤痕通常会产生功能和审美缺陷，从而严重影响个人在社会中的功能。我们的长期目标是开发诊断和治疗方法，促进皮肤伤口的正常愈合，而不会形成过多的疤痕。我们的初步工作集中在证明增生性瘢痕兔模型与人类病情的临床相关性。这个模型以多种方式模拟人类的情况，包括对类固醇和闭塞治疗的反应，以及随着年龄的增长而减少的肥大。最重要的是，我们的模型和人类的肥大是由于细胞外基质的过度产生，主要是胶原。创伤过程中最强大的胶原合成调节因子是细胞因子TGFβ家族。我们的中心假设是，TGFbeta调控伤口愈合和瘢痕形成的方式是，其三种异构体的优势及其丰度和出现的时间顺序决定了伤口愈合反应的瘢痕形成结果。此外，我们假设TGFbeta受体(I和11)和TGFbeta细胞内信号成分中的Smad成员在维持肥大状态中发挥关键作用。这些假说将使用我们的临床相关的兔增生性瘢痕模型进行验证。我们的具体目标是：(1)利用我们独特的兔耳增生性瘢痕模型，支持这一假说，即TGFβ亚型出现的比例和时间模式及其对胶原合成的总体影响对于增生性瘢痕与正常瘢痕的发展至关重要。(2)利用基因治疗的方法，验证TGFβ受体在增生性瘢痕发生发展中的作用的假说，即TGFβ受体在时间上、绝对数量和比例上的变化在增生性瘢痕的发生发展中起重要作用，即过表达I型和II型受体，并用显性的阴性受体阻断它们。这种在体内改变受体表达的新方法将被检验其潜在的治疗意义。(3)通过病毒和非病毒基因治疗方法改变TGFβ的信号转导途径，改变Smad3、4、7的表达，并检测其对TGFβ的表达、增生性瘢痕的发生发展和I型胶原表达的影响，进一步验证TGFβ亚型表达在增生性瘢痕发生发展中的作用。